Abstract
Objectives:The safety and potential efficacy of rituximab was examined in diffuse cutaneous systemic sclerosis (dc-SSc).Methods:A 24 week open-label study in which eight patients with dc-SSc received an infusion of 1000...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have